Cargando…
Use of Favipiravir in Lactating Mother With COVID-19
Autores principales: | Karabayır, Nalan, Öçal Doğan, Özlem, Canbeyli, Gülçin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Pediatrics Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849531/ https://www.ncbi.nlm.nih.gov/pubmed/35110126 http://dx.doi.org/10.5152/TurkArchPediatr.2021.21117 |
Ejemplares similares
-
EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA
por: Delen, Leman Acun, et al.
Publicado: (2022) -
Manifestations in Neonates Born to COVID-19 Positive Mothers
por: Jain, Parul, et al.
Publicado: (2020) -
Hematological Malignancy Patients, COVID-19, and Favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021) -
Favipiravir and the Need for Early Ambulatory Treatment of COVID-19
por: Korman, Tony M.
Publicado: (2021) -
Effect of favipiravir and an anti-inflammatory strategy for COVID-19
por: Yamamura, Hitoshi, et al.
Publicado: (2020)